Skip to content
Clinical Trials – home
BulgariaBack to Bulgaria

Clinical trials in Kirdzhali – page 2

27 clinical trials in Kirdzhali, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.

Kirdzhali at a glance
27
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

27 trials in Kirdzhali

Open in trial search
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Hypertriglyceridaemia

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Anifrolumab
  • Sponsor:AstraZeneca AB
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Filgotinib
  • Sponsor:Alfasigma S.p.A.

Atrial fibrillation

Not recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen - Cilag International
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Karuna Therapeutics Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Aticaprant
  • Sponsor:Janssen - Cilag International

Schizophrenia

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Valbenazine Ditosylate
  • Sponsor:Neurocrine Biosciences Inc.

Cognitive disorder+1

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:(2R,3S)-2-Amino-3-Hydroxy-3-Pyridin-4-Yl-1-Pyrrolidin-1-Ylpropan-1-One (2R,3R)-2,3-Dihydroxybutanedioic Acid
  • Sponsor:Recognify Life Sciences Inc.
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Acp-204 Tartrate
  • Sponsor:Acadia Pharmaceuticals Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Karuna Therapeutics Inc.

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Kirdzhali

What the registry says about research in the country

01 Cardiovascular Research

Innovative trials focusing on acute myocardial infarction prevention and treatment, alongside studies evaluating new therapies for atrial fibrillation. Research includes novel approaches to stroke prevention and management of cardiac emergencies.

  • Stroke Prevention Studies
  • Heart Attack Management
  • Cardiac Rhythm Disorders

Current studies explore self-administered treatments and comparative effectiveness of new anticoagulants.

02 Mental Health Studies

Comprehensive research into major depressive disorder and schizophrenia, evaluating both established and novel therapeutic approaches. Studies include long-term safety assessments and treatment of cognitive impairment.

  • Depression Management
  • Schizophrenia Treatment
  • Cognitive Function

Multiple trials are examining adjunctive therapies and new compounds for treatment-resistant cases.

03 Neurological Disorders

Advanced research focusing on Alzheimer's Disease Psychosis, investigating new therapeutic options for symptom management and long-term treatment outcomes.

  • Psychosis Management
  • Long-term Safety Studies
  • Cognitive Enhancement

Current studies evaluate both short-term efficacy and extended safety profiles of novel treatments.

04 Metabolic Conditions

Targeted research on hypertriglyceridemia, including both severe and moderate forms. Studies focus on innovative treatments for lipid management.

  • Lipid Level Management
  • Metabolic Disorders
  • Treatment Safety

Studies examine long-term effectiveness and safety of new therapeutic approaches.

05 Autoimmune Research

Specialized studies investigating treatments for Systemic Lupus Erythematosus and axial spondyloarthritis, focusing on disease activity reduction and symptom management.

  • Lupus Treatment
  • Inflammatory Conditions
  • Disease Modification

Research emphasizes novel biological therapies and their impact on disease progression.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.